Neurosense Therapeutics Stock Price History
NRSN Stock | USD 0.90 0.02 2.17% |
If you're considering investing in Neurosense Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neurosense Therapeutics stands at 0.90, as last reported on the 24th of November, with the highest price reaching 0.96 and the lowest price hitting 0.85 during the day. Neurosense Therapeutics appears to be very risky, given 3 months investment horizon. Neurosense Therapeutics has Sharpe Ratio of 0.0559, which conveys that the firm had a 0.0559% return per unit of risk over the last 3 months. We have found thirty technical indicators for Neurosense Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Neurosense Therapeutics' Downside Deviation of 4.87, mean deviation of 3.78, and Risk Adjusted Performance of 0.0459 to check out if our risk estimates are consistent with your expectations.
At this time, Neurosense Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 24th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 5.3 M, though Total Stockholder Equity is likely to grow to (1.8 M). . As of the 24th of November 2024, Price Earnings Ratio is likely to drop to -1.11. In addition to that, Price Book Value Ratio is likely to grow to -5.43. Neurosense Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neurosense |
Sharpe Ratio = 0.0559
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NRSN | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.43 actual daily | 48 52% of assets are more volatile |
Expected Return
0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Neurosense Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurosense Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.1496 | Book Value (0.09) | Enterprise Value 16.7 M | Enterprise Value Ebitda (1.16) | Shares Float 13.5 M |
Neurosense Therapeutics Stock Price History Chart
There are several ways to analyze Neurosense Stock price data. The simplest method is using a basic Neurosense candlestick price chart, which shows Neurosense Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 13, 2024 | 1.35 |
Lowest Price | August 30, 2024 | 0.89 |
Neurosense Therapeutics November 24, 2024 Stock Price Synopsis
Various analyses of Neurosense Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurosense Stock. It can be used to describe the percentage change in the price of Neurosense Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurosense Stock.Neurosense Therapeutics Price Daily Balance Of Power | (0.18) | |
Neurosense Therapeutics Price Rate Of Daily Change | 0.98 | |
Neurosense Therapeutics Price Action Indicator | (0.01) |
Neurosense Therapeutics November 24, 2024 Stock Price Analysis
Neurosense Stock Price History Data
The price series of Neurosense Therapeutics for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 has a statistical range of 0.64 with a coefficient of variation of 15.08. The daily prices for the period are spread out with arithmetic mean of 1.16. The median price for the last 90 days is 1.22.Open | High | Low | Close | Volume | ||
11/24/2024 | 0.92 | 0.96 | 0.85 | 0.90 | ||
11/22/2024 | 0.92 | 0.96 | 0.85 | 0.90 | 117,557 | |
11/21/2024 | 0.98 | 1.02 | 0.91 | 0.92 | 143,515 | |
11/20/2024 | 1.11 | 1.12 | 0.97 | 0.99 | 195,059 | |
11/19/2024 | 1.15 | 1.19 | 1.11 | 1.12 | 167,805 | |
11/18/2024 | 1.25 | 1.26 | 1.14 | 1.18 | 121,022 | |
11/15/2024 | 1.28 | 1.28 | 1.19 | 1.23 | 178,762 | |
11/14/2024 | 1.30 | 1.33 | 1.27 | 1.30 | 50,930 | |
11/13/2024 | 1.35 | 1.35 | 1.27 | 1.33 | 111,044 | |
11/12/2024 | 1.31 | 1.35 | 1.30 | 1.33 | 48,211 | |
11/11/2024 | 1.30 | 1.35 | 1.30 | 1.32 | 121,328 | |
11/08/2024 | 1.30 | 1.30 | 1.26 | 1.29 | 23,982 | |
11/07/2024 | 1.31 | 1.34 | 1.23 | 1.29 | 77,388 | |
11/06/2024 | 1.29 | 1.30 | 1.24 | 1.28 | 100,415 | |
11/05/2024 | 1.25 | 1.25 | 1.21 | 1.25 | 72,999 | |
11/04/2024 | 1.26 | 1.34 | 1.14 | 1.23 | 388,593 | |
11/01/2024 | 1.30 | 1.38 | 1.23 | 1.27 | 492,402 | |
10/31/2024 | 1.31 | 1.32 | 1.12 | 1.25 | 361,975 | |
10/30/2024 | 1.32 | 1.34 | 1.29 | 1.30 | 38,221 | |
10/29/2024 | 1.39 | 1.40 | 1.27 | 1.34 | 111,917 | |
10/28/2024 | 1.30 | 1.40 | 1.29 | 1.35 | 810,726 | |
10/25/2024 | 1.25 | 1.32 | 1.24 | 1.27 | 331,765 | |
10/24/2024 | 1.14 | 1.24 | 1.05 | 1.21 | 312,395 | |
10/23/2024 | 1.11 | 1.17 | 1.11 | 1.15 | 34,040 | |
10/22/2024 | 1.11 | 1.15 | 1.07 | 1.15 | 26,070 | |
10/21/2024 | 1.08 | 1.10 | 1.04 | 1.10 | 55,785 | |
10/18/2024 | 1.14 | 1.15 | 1.05 | 1.07 | 60,942 | |
10/17/2024 | 1.00 | 1.10 | 0.96 | 1.10 | 100,307 | |
10/16/2024 | 0.97 | 1.00 | 0.92 | 0.98 | 143,877 | |
10/15/2024 | 1.16 | 1.22 | 0.95 | 0.96 | 388,577 | |
10/14/2024 | 1.09 | 1.12 | 1.03 | 1.09 | 148,119 | |
10/11/2024 | 1.22 | 1.24 | 1.09 | 1.13 | 263,292 | |
10/10/2024 | 1.19 | 1.22 | 1.10 | 1.22 | 90,455 | |
10/09/2024 | 1.24 | 1.25 | 1.09 | 1.22 | 221,439 | |
10/08/2024 | 1.26 | 1.27 | 1.22 | 1.22 | 30,464 | |
10/07/2024 | 1.23 | 1.29 | 1.21 | 1.25 | 74,393 | |
10/04/2024 | 1.24 | 1.28 | 1.22 | 1.26 | 50,187 | |
10/03/2024 | 1.19 | 1.28 | 1.19 | 1.22 | 48,584 | |
10/02/2024 | 1.20 | 1.24 | 1.20 | 1.21 | 27,884 | |
10/01/2024 | 1.23 | 1.23 | 1.17 | 1.22 | 65,843 | |
09/30/2024 | 1.27 | 1.37 | 1.24 | 1.27 | 64,972 | |
09/27/2024 | 1.30 | 1.30 | 1.25 | 1.28 | 64,438 | |
09/26/2024 | 1.20 | 1.28 | 1.11 | 1.27 | 106,077 | |
09/25/2024 | 1.33 | 1.33 | 1.17 | 1.20 | 185,650 | |
09/24/2024 | 1.26 | 1.29 | 0.90 | 1.25 | 802,251 | |
09/23/2024 | 1.29 | 1.32 | 1.26 | 1.30 | 61,212 | |
09/20/2024 | 1.31 | 1.35 | 1.20 | 1.30 | 93,373 | |
09/19/2024 | 1.39 | 1.39 | 1.31 | 1.35 | 67,864 | |
09/18/2024 | 1.33 | 1.37 | 1.31 | 1.35 | 77,287 | |
09/17/2024 | 1.35 | 1.42 | 1.31 | 1.34 | 125,676 | |
09/16/2024 | 1.25 | 1.46 | 1.25 | 1.34 | 334,495 | |
09/13/2024 | 1.35 | 1.35 | 1.19 | 1.35 | 196,729 | |
09/12/2024 | 1.28 | 1.35 | 1.22 | 1.29 | 316,417 | |
09/11/2024 | 1.15 | 1.31 | 1.06 | 1.22 | 488,294 | |
09/10/2024 | 1.12 | 1.18 | 1.05 | 1.16 | 255,007 | |
09/09/2024 | 0.96 | 1.14 | 0.94 | 1.11 | 713,544 | |
09/06/2024 | 0.94 | 0.94 | 0.88 | 0.94 | 94,085 | |
09/05/2024 | 0.95 | 0.97 | 0.93 | 0.95 | 81,688 | |
09/04/2024 | 0.98 | 0.99 | 0.93 | 0.97 | 102,253 | |
09/03/2024 | 0.92 | 0.99 | 0.88 | 0.98 | 592,151 | |
08/30/2024 | 0.73 | 0.95 | 0.73 | 0.89 | 1,360,765 |
About Neurosense Therapeutics Stock history
Neurosense Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurosense is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurosense Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurosense Therapeutics stock prices may prove useful in developing a viable investing in Neurosense Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 13.6 M | 14.3 M | |
Net Loss | -3.6 M | -3.8 M |
Neurosense Therapeutics Stock Technical Analysis
Neurosense Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Neurosense Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neurosense Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Neurosense Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurosense to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0459 | |||
Jensen Alpha | 0.088 | |||
Total Risk Alpha | (0.60) | |||
Sortino Ratio | 0.0271 | |||
Treynor Ratio | 0.1854 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Return On Assets (1.51) | Return On Equity (4.95) |
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.